Cancer Research  Folkman
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 383-, April 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiramoto, R.
Right arrow Articles by Pressman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiramoto, R.
Right arrow Articles by Pressman, D.

Immunochemical Differentiation of Rhabdomyosarcomas*

R. Hiramoto, J. Jurandowski, J. Bernecky and D. Pressman

( Department of Biochemistry Research, Roswell Park Memorial Institute, Buffalo 3, N.Y.)

When six rhabdomyosarcomas were stained with antisera by the fluorescein label technic, three (classified as embryonal and usually difficult to diagnose as rhabdomyosarcoma) appeared to contain myosin, since they reacted with antimyosin antibody, whereas the remaining three, which were easier to classify as typical rhabdomyosarcoma histologically, appeared to contain no myosin. Anticonnective tissue serum gave different results in that the embryonal cells did not contain connective tissue antigenic components, whereas the typical rhabdomyosarcoma cells did (except for one of the adult rhabdomyosarcomas where only partial staining was seen). The question arises whether the adult muscle tumors are of muscle origin or of stromal origin. If these tumors come from skeletal muscle cells, they must have lost the ability to synthesize myosin in amounts detectable by the fluorescent antibody technic.

* Presented at the 51st Annual Meeting of the American Association for Cancer Research, Chicago, Illinois, April, 1960.

Received 9/29/60.


This article has been cited by other articles:


Home page
Arch NeurolHome page
A. S. Penn, R. A. Cloak, and L. P. Rowland
Myosin From Normal and Dystrophic Human Muscle: Immunochemical and Electrophoretic Studies
Arch Neurol, August 1, 1972; 27(2): 159 - 173.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.